- Home
- LRHC vs CDIO Comparison
LRHC vs CDIO Comparison
Compare LRHC & CDIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRHC
- CDIO
- Stock Information
- Founded
- LRHC 2004
- CDIO 2017
- Country
- LRHC United States
- CDIO United States
- Employees
- LRHC N/A
- CDIO N/A
- Industry
- LRHC
- CDIO Biotechnology: Commercial Physical & Biological Resarch
- Sector
- LRHC
- CDIO Health Care
- Exchange
- LRHC Nasdaq
- CDIO Nasdaq
- Market Cap
- LRHC 5.4M
- CDIO 6.4M
- IPO Year
- LRHC 2023
- CDIO N/A
- Fundamental
- Price
- LRHC $7.87
- CDIO $3.88
- Analyst Decision
- LRHC
- CDIO
- Analyst Count
- LRHC 0
- CDIO 0
- Target Price
- LRHC N/A
- CDIO N/A
- AVG Volume (30 Days)
- LRHC 48.3K
- CDIO 20.1K
- Earning Date
- LRHC 08-18-2025
- CDIO 11-12-2025
- Dividend Yield
- LRHC N/A
- CDIO N/A
- EPS Growth
- LRHC N/A
- CDIO N/A
- EPS
- LRHC N/A
- CDIO N/A
- Revenue
- LRHC $78,037,079.00
- CDIO $19,507.00
- Revenue This Year
- LRHC N/A
- CDIO $1,434.82
- Revenue Next Year
- LRHC N/A
- CDIO $4,661.91
- P/E Ratio
- LRHC N/A
- CDIO N/A
- Revenue Growth
- LRHC 54.92
- CDIO N/A
- 52 Week Low
- LRHC $4.33
- CDIO $3.22
- 52 Week High
- LRHC $142.40
- CDIO $53.10
- Technical
- Relative Strength Index (RSI)
- LRHC 58.69
- CDIO 52.10
- Support Level
- LRHC $6.86
- CDIO $3.65
- Resistance Level
- LRHC $9.72
- CDIO $3.98
- Average True Range (ATR)
- LRHC 0.81
- CDIO 0.22
- MACD
- LRHC 0.21
- CDIO 0.03
- Stochastic Oscillator
- LRHC 56.26
- CDIO 72.07
About LRHC La Rosa Holdings Corp.
La Rosa Holdings Corp operates in the U.S. residential real estate market. It is a holding company for agent-centric, technology-integrated, cloud-based, multi-service real estate companies. The company's business is organized based on the services it provides internally to the agents and to the public, which are residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The company has six reportable segments, namely: Real Estate Brokerage Services (Residential), Franchising Services, Coaching Services, Property Management, Real Estate Brokerage Services (Commercial), and Title Settlement and Insurance. It derives maximum revenue from the Real Estate Brokerage Services (Residential) segment.
About CDIO Cardio Diagnostics Holdings Inc. Common stock
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.